Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,510 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00623064 | Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer | completed | Phase 1 | 18 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 1, 2014 |
| clinicaltrials |
| NCT00471536 | Pazopanib in Treating Patients With Metastatic Urothelial Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 3 | May 30, 2014 | clinicaltrials |
| NCT01711112 | Salvage Docetaxel for Pretreated Urothelial Cancer | completed | Phase 2 | 31 | Samsung Medical CenterOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT01240824 | Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer(BCG) | completed | Early Phase 1 | 3 | University of VirginiaOTHER | 1 | Apr 14, 2014 | clinicaltrials |
| NCT02113501 | Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study | completed | — | 200 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Apr 14, 2014 | clinicaltrials |
| NCT01395225 | Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer | completed | — | 32 | University of British ColumbiaOTHER | 1 | Mar 13, 2014 | clinicaltrials |
| NCT01304173 | Retrospective Chart Review of Valstar | completed | — | 113 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00002490 | Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer | completed | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00003814 | Eflornithine in Treating Patients With Bladder Cancer | completed | Phase 3 | 450 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00024349 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | completed | Phase 3 | 350 | University Hospital BirminghamOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | completed | Phase 2 | 45 | Medical Research CouncilOTHER_GOV | 8 | Dec 4, 2013 | clinicaltrials |
| NCT00006376 | R115777 in Treating Patients With Advanced Bladder Cancer | completed | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00016237 | Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment | completed | Phase 1 | — | EMD SeronoINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00052637 | Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer | completed | Phase 3 | — | PhotocureINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00233402 | Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy | completed | Phase 3 | 789 | PhotocureINDUSTRY | 5 | Oct 11, 2013 | clinicaltrials |
| NCT00412971 | A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer | completed | Phase 3 | 233 | PhotocureINDUSTRY | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00033436 | Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer | completed | Phase 3 | 330 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01939756 | Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms(Baobab) | completed | Phase 1 / Phase 2 | 50 | Savino M. Di StasiOTHER | 1 | Sep 11, 2013 | clinicaltrials |
| NCT00002949 | Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | completed | Phase 1 | 33 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00004203 | Oxaliplatin in Treating Patients With Metastatic Bladder Cancer | completed | Phase 2 | 20 | University of ChicagoOTHER | 2 | Sep 5, 2013 | clinicaltrials |
| NCT00005086 | Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer | completed | Phase 2 | 6 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00006105 | Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer | completed | Phase 2 | 37 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT01031875 | Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment | completed | Phase 2 | 41 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01329107 | Multimodal Rehabilitation Program to Bladder Cancer Patients(MRPBC) | completed | N/A | 129 | University of AarhusOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00028860 | Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer | completed | Phase 2 | — | Tulane University Health Sciences CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00002684 | Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer | completed | Phase 2 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00002919 | Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer | completed | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003105 | Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer | completed | Phase 1 / Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003342 | Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003133 | Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | completed | Phase 1 | 15 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00829920 | The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease | completed | — | 44 | University of Colorado, DenverOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00002990 | Surgery and BCG in Treating Patients With Bladder Cancer | completed | Phase 3 | 1,288 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00014274 | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | completed | Phase 2 / Phase 3 | 238 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | completed | Phase 3 | 608 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 16 | Jun 12, 2013 | clinicaltrials |
| NCT00072150 | Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00045630 | S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium | completed | Phase 2 | 77 | SWOG Cancer Research NetworkNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00963859 | Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder | completed | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00002917 | Paclitaxel in Treating Patients With Early-Stage Bladder Cancer | completed | Phase 1 / Phase 2 | — | Mary Babb Randolph Cancer Center at West Virginia University HospitalsOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00006034 | Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer | completed | Phase 3 | — | IntracelINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00303654 | Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection | completed | N/A | 24 | Roei Medical Technologies Ltd.INDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01810445 | Endoscopic Subsurface Optical Imaging for Cancer Detection | completed | — | 26 | University of California, DavisOTHER | 0 | Mar 13, 2013 | clinicaltrials |
| NCT01801644 | Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer | completed | N/A | 60 | Barmherzige Brüder ViennaOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00006124 | Celecoxib in Treating Patients With Bladder Cancer | completed | Phase 2 / Phase 3 | 152 | National Cancer Institute (NCI)NIH | 1 | Feb 13, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 2, 2014source: clinicaltrials